Brief: Moderna Receives European Commission Marketing Authorization For mCOMBRIAX
21/04/2026 18:23
April 21 (Reuters) - Moderna Inc MRNA.O: MODERNA RECEIVES EUROPEAN COMMISSION MARKETING AUTHORIZATION FOR MCOMBRIAX, MODERNA'S MRNA COMBINATION VACCINE AGAINST INFLUENZA AND COVID-19 MODERNA: MCOMBRIAX WILL BE MADE AVAILABLE IN EUROPEAN UNION, SUBJECT TO NATIONAL REGULATORY AND ACCESS PROCEDURES MODERNA: EC GRANTED MARKETING AUTHORIZATION FOR MRNA-1083 FOR INDIVIDUALS 50 YEARS OF AGE AND OLDER Further company coverage: MRNA.O ((Reuters.Briefs@thomsonreuters.com;))